Cargando…

Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate

The title compounds, [FeCl(2)(C(15)H(20)N(2))(4)], (I), [FeBr(2)(C(15)H(20)N(2))(4)], (II), and [FeBr(2)(C(15)H(20)N(2))(4)]·2C(4)H(10)O, (IIb), respectively, all have triclinic symmetry, with (I) and (II) being isotypic. The Fe(II) atoms in each of the structures are located on an inversion center....

Descripción completa

Detalles Bibliográficos
Autores principales: Mafua, Roger, Jenny, Titus, Labat, Gael, Neels, Antonia, Stoeckli-Evans, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158527/
https://www.ncbi.nlm.nih.gov/pubmed/25249858
http://dx.doi.org/10.1107/S1600536814014056
_version_ 1782334066994970624
author Mafua, Roger
Jenny, Titus
Labat, Gael
Neels, Antonia
Stoeckli-Evans, Helen
author_facet Mafua, Roger
Jenny, Titus
Labat, Gael
Neels, Antonia
Stoeckli-Evans, Helen
author_sort Mafua, Roger
collection PubMed
description The title compounds, [FeCl(2)(C(15)H(20)N(2))(4)], (I), [FeBr(2)(C(15)H(20)N(2))(4)], (II), and [FeBr(2)(C(15)H(20)N(2))(4)]·2C(4)H(10)O, (IIb), respectively, all have triclinic symmetry, with (I) and (II) being isotypic. The Fe(II) atoms in each of the structures are located on an inversion center. They have octa­hedral FeX (2)N(4) (X = Cl and Br, respectively) coordination spheres with the Fe(II) atom coordinated by two halide ions in a trans arrangement and by the tertiary N atom of four aryl­imidazole ligands [1-(2,6-diiso­propyl­phen­yl)-1H-imidazole] in the equatorial plane. In the two independent ligands, the benzene and imidazole rings are almost normal to one another, with dihedral angles of 88.19 (15) and 79.26 (14)° in (I), 87.0 (3) and 79.2 (3)° in (II), and 84.71 (11) and 80.58 (13)° in (IIb). The imidazole rings of the two independent ligand mol­ecules are inclined to one another by 70.04 (15), 69.3 (3) and 61.55 (12)° in (I), (II) and (IIb), respectively, while the benzene rings are inclined to one another by 82.83 (13), 83.0 (2) and 88.16 (12)°, respectively. The various dihedral angles involving (IIb) differ slightly from those in (I) and (II), probably due to the close proximity of the diethyl ether solvent mol­ecule. There are a number of C—H⋯halide hydrogen bonds in each mol­ecule involving the CH groups of the imidazole units. In the structures of compounds (I) and (II), mol­ecules are linked via pairs of C—H⋯halogen hydrogen bonds, forming chains along the a axis that enclose R (2) (2)(12) ring motifs. The chains are linked by C—H⋯π inter­actions, forming sheets parallel to (001). In the structure of compound (IIb), mol­ecules are linked via pairs of C—H⋯halogen hydrogen bonds, forming chains along the b axis, and the diethyl ether solvent mol­ecules are attached to the chains via C—H⋯O hydrogen bonds. The chains are linked by C—H⋯π inter­actions, forming sheets parallel to (001). In (I) and (II), the methyl groups of an isopropyl group are disordered over two positions [occupancy ratio = 0.727 (13):0.273 (13) and 0.5:0.5, respectively]. In (IIb), one of the ethyl groups of the diethyl ether solvent mol­ecule is disordered over two positions (occupancy ratio = 0.5:0.5).
format Online
Article
Text
id pubmed-4158527
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-41585272014-09-23 Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate Mafua, Roger Jenny, Titus Labat, Gael Neels, Antonia Stoeckli-Evans, Helen Acta Crystallogr Sect E Struct Rep Online Research Communications The title compounds, [FeCl(2)(C(15)H(20)N(2))(4)], (I), [FeBr(2)(C(15)H(20)N(2))(4)], (II), and [FeBr(2)(C(15)H(20)N(2))(4)]·2C(4)H(10)O, (IIb), respectively, all have triclinic symmetry, with (I) and (II) being isotypic. The Fe(II) atoms in each of the structures are located on an inversion center. They have octa­hedral FeX (2)N(4) (X = Cl and Br, respectively) coordination spheres with the Fe(II) atom coordinated by two halide ions in a trans arrangement and by the tertiary N atom of four aryl­imidazole ligands [1-(2,6-diiso­propyl­phen­yl)-1H-imidazole] in the equatorial plane. In the two independent ligands, the benzene and imidazole rings are almost normal to one another, with dihedral angles of 88.19 (15) and 79.26 (14)° in (I), 87.0 (3) and 79.2 (3)° in (II), and 84.71 (11) and 80.58 (13)° in (IIb). The imidazole rings of the two independent ligand mol­ecules are inclined to one another by 70.04 (15), 69.3 (3) and 61.55 (12)° in (I), (II) and (IIb), respectively, while the benzene rings are inclined to one another by 82.83 (13), 83.0 (2) and 88.16 (12)°, respectively. The various dihedral angles involving (IIb) differ slightly from those in (I) and (II), probably due to the close proximity of the diethyl ether solvent mol­ecule. There are a number of C—H⋯halide hydrogen bonds in each mol­ecule involving the CH groups of the imidazole units. In the structures of compounds (I) and (II), mol­ecules are linked via pairs of C—H⋯halogen hydrogen bonds, forming chains along the a axis that enclose R (2) (2)(12) ring motifs. The chains are linked by C—H⋯π inter­actions, forming sheets parallel to (001). In the structure of compound (IIb), mol­ecules are linked via pairs of C—H⋯halogen hydrogen bonds, forming chains along the b axis, and the diethyl ether solvent mol­ecules are attached to the chains via C—H⋯O hydrogen bonds. The chains are linked by C—H⋯π inter­actions, forming sheets parallel to (001). In (I) and (II), the methyl groups of an isopropyl group are disordered over two positions [occupancy ratio = 0.727 (13):0.273 (13) and 0.5:0.5, respectively]. In (IIb), one of the ethyl groups of the diethyl ether solvent mol­ecule is disordered over two positions (occupancy ratio = 0.5:0.5). International Union of Crystallography 2014-07-19 /pmc/articles/PMC4158527/ /pubmed/25249858 http://dx.doi.org/10.1107/S1600536814014056 Text en © Mafua et al. 2014 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/2.0/uk/
spellingShingle Research Communications
Mafua, Roger
Jenny, Titus
Labat, Gael
Neels, Antonia
Stoeckli-Evans, Helen
Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate
title Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate
title_full Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate
title_fullStr Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate
title_full_unstemmed Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate
title_short Crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1H-imidazole-κN (3)]iron(II) diethyl ether disolvate
title_sort crystal structures of trans-di­chlorido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1h-imidazole-κn (3)]iron(ii), trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1h-imidazole-κn (3)]iron(ii) and trans-di­bromido­tetra­kis­[1-(2,6-diiso­propyl­phen­yl)-1h-imidazole-κn (3)]iron(ii) diethyl ether disolvate
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158527/
https://www.ncbi.nlm.nih.gov/pubmed/25249858
http://dx.doi.org/10.1107/S1600536814014056
work_keys_str_mv AT mafuaroger crystalstructuresoftransdichloridotetrakis126diisopropylphenyl1himidazolekn3ironiitransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiiandtransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiidiethyletherdisolvate
AT jennytitus crystalstructuresoftransdichloridotetrakis126diisopropylphenyl1himidazolekn3ironiitransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiiandtransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiidiethyletherdisolvate
AT labatgael crystalstructuresoftransdichloridotetrakis126diisopropylphenyl1himidazolekn3ironiitransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiiandtransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiidiethyletherdisolvate
AT neelsantonia crystalstructuresoftransdichloridotetrakis126diisopropylphenyl1himidazolekn3ironiitransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiiandtransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiidiethyletherdisolvate
AT stoecklievanshelen crystalstructuresoftransdichloridotetrakis126diisopropylphenyl1himidazolekn3ironiitransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiiandtransdibromidotetrakis126diisopropylphenyl1himidazolekn3ironiidiethyletherdisolvate